← Back to all substances
C

atorvastatin

220ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Atorvastatin calcium tablets are indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults wit...

Known as: Atorvastatin calcium
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
318,653
Total in FDA
82%
Serious Reports
25
Fatal Outcomes

Seriousness

Serious
412
Non-Serious
88

Sex Distribution

Male
165
Female
320
Unknown
15

Age Distribution

18-40
12
41-64
211
65-84
200
85+
19
Unknown
58

Outcomes

Recovered/Resolved
193
Recovering/Resolving
116
Not Recovered/Not Resolved
282
Recovered with Sequelae
45
Fatal
25
Unknown
614

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-193d5b
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...